Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02909686 · ClinicalTrials.gov registry record · NA
Effects of Botanical Microglia Modulators in Gulf War Illness
A NA study, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- NA
- Development phase
- 36
- Enrollment target
NCT02909686 is a NA study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 36 participants.
The verdict
NCT02909686, a NA study, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
Study Summary
The overall objective of this protocol is to test if Gulf War Illness (GWI) involves chronic inflammation that cannot be measured with typical techniques. The investigators will be observing the effects of nine different botanical compounds (supplements) that are known to suppress inflammation. If one of those supplements helps the symptoms of GWI, it will give the investigators information about what is wrong in people with GWI.
Interventions
- DIETARY_SUPPLEMENT Curcumin
- DIETARY_SUPPLEMENT Fisetin
- DIETARY_SUPPLEMENT Luteolin
- DIETARY_SUPPLEMENT Boswellia Serrata
- DIETARY_SUPPLEMENT Epimedium
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2016-07 |
| Est. Completion | 2022-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02909686
The ClinicalTrials.gov registry entry for NCT02909686 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Curcumin is the first listed.
NCT02909686 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02909686 about?
NCT02909686 is a clinical study titled "Effects of Botanical Microglia Modulators in Gulf War Illness". The overall objective of this protocol is to test if Gulf War Illness (GWI) involves chronic inflammation that cannot be measured with typical techniques. The investigators will be observing the effects of nine different botanical compounds (supplements) that are known to suppress inflammation. If o...
What is the current status of trial NCT02909686?
This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2016-07. Estimated completion is 2022-09.
What interventions are being tested in trial NCT02909686?
The interventions under investigation include: Curcumin (DIETARY_SUPPLEMENT), Fisetin (DIETARY_SUPPLEMENT), Luteolin (DIETARY_SUPPLEMENT), Boswellia Serrata (DIETARY_SUPPLEMENT), Epimedium (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02909686?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.